ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia von Tonino, S H, van Laar, J, van Oers, M H, Wang, J Y, Eldering, E, Kater, A P

Volltext

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Dreyling, M., Ghielmini, M., Rule, S., Salles, G., Ladetto, M., Tonino, S.H., Herfarth, K., Seymour, J.F., Jerkeman, M.

Volltext

R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia von Tonino, S H, van Gelder, M, Eldering, E, van Oers, M H, Kater, A P

Volltext

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies von van Rhee, K P, de Vroom, S L, van Hest, R M, van der Linden, P D, Tonino, S H, Molendijk, E, Mathôt, R A A, Blijlevens, N M A, Knibbe, C A J, Bruggemann, R J M, Geerlings, S E

Volltext

Dichotomy in NF-[kappa]B signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering von Tromp, J M, Tonino, S H, Elias, J A, Jaspers, A, Luijks, D M, Kater, A P, Van Lier, R A W, Van Oers, M H J, Eldering, E

Volltext

Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40 TLR9 triggering von Tromp, J M, Tonino, S H, Elias, J A, Jaspers, A, Luijks, D M, Kater, A P, van Lier, R A W, van Oers, M H J, Eldering, E

Volltext

T‐CELL SUBSET COMPOSITION AND FUNCTIONALITY IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA von Amaador, K, Martens, A. W. J, de Boer, R, Rietveld, J. M, Eldering, E, Kersten, M. J, Kater, A. P, Vos, J. M. I, Tonino, S. H

Volltext

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines tor diagnosis, treatment and follow-up von Dreyling, M., Ghielmini, M., Rule, S., Salles, G., Ladetto, M., Tonino, S. H., Herfarth, K., Seymour, J. F., Jerkeman, M.

Volltext

Chest pain in sickle cell disease von Tonino, S H, Nur, E, Otten, H M, Wykrzykowska, J J, Hoekstra, J B L, Biemond, B J

Volltext

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transp... von Kersten, Marie Jose, Driessen, Julia, Zijlstra, Josee M., Plattel, Wouter J., Morschhauser, Franck, Lugtenburg, Pieternella J., Brice, Pauline, Hutchings, Martin, Gastinne, Thomas, Liu, Roberto, Burggraaff, Coreline N., Nijland, Marcel, Tonino, Sanne H., Arens, Anne I. J., Valkema, Roelf, van Tinteren, Harm, Lopez-Yurda, Marta, Diepstra, Arjan, De Jong, Daphne, Hagenbeek, Anton

Volltext

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL von van der Straten, Lina, Stege, Claudia A. M., Kersting, Sabina, Nasserinejad, Kazem, Dubois, Julie, Dobber, Johan A., Mellink, Clemens H. M., van der Kevie-Kersemaekers, Anne-Marie F., Evers, Ludo M., de Boer, Fransien, Koene, Harry R., Schreurs, John, van der Klift, Marjolein, Velders, Gerjo A., van der Spek, Ellen, van der Straaten, Hanneke M., Hoogendoorn, Mels, van Gelder, Michel, Posthuma, Eduardus F. M., Visser, Hein P. J., Houtenbos, Ilse, Idink, Cecile A. M., Issa, Djamila E., Dompeling, Ellen C., van Zaanen, Henk C. T., Veelken, J. Hendrik, Levenga, Henriette, Tick, Lidwine W., Terpstra, Wim E., Tonino, Sanne H., Westerweel, Peter E., Langerak, Anton W., Kater, Arnon P., Levin, Mark-David, Beckers, M. M. J., Bekker, A., Bellido, M., de Boer, F., Broers, R., Chamuleau, M., Croockewit, A. J., Dompeling, E. C., Eefting, M., van Gelder, M., Hoogendoorn, M., Houtenbos, I., Doorduijn, J. K., Droogendijk, J., van der Griend, R., de Heer, K., Henkens, C. M. A., Idink, C. A. M., Issa, D. E., van Kampen, R., Kater, A. P., Kersting, S., van der Klift, M., Laterveer, L., Levenga, H., Levin, M-D., Mous, R., Nijland, M., Nijziel, M., van Norden, Y., Posthuma, E. F. M., te Raa, G. D., Raymakers, R. A. P., Regelink, J. C., Sandberg, Y., Schaafsma, M. R., Silbermann, M. H., van der Spek, A. C., van der Straaten, H. M., Tanis, B., Terpstra, W. E., Tick, L. W., Tonino, S. H., Veelken, J. H., Velders, G. A., Vlasveld, L., Visser, H. P. J., Vos, J. M. I., Wittebol, S., van Zaanen, H. C. T.

Volltext

Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP von Driessen, Julia, Kersten, Marie José, Visser, Lydia, van den Berg, Anke, Tonino, Sanne H., Zijlstra, Josée M., Lugtenburg, Pieternella J., Morschhauser, Franck, Hutchings, Martin, Amorim, Sandy, Gastinne, Thomas, Nijland, Marcel, Zwezerijnen, Gerben J. C., Boellaard, Ronald, de Vet, Henrica C. W., Arens, Anne I. J., Valkema, Roelf, Liu, Roberto D. K., Drees, Esther E. E., de Jong, Daphne, Plattel, Wouter J., Diepstra, Arjan

Volltext

Risk of male breast cancer after Hodgkin lymphoma von de Vries, Simone, Krul, Inge M, Schaapveld, Michael, Janus, Cecile P M, Rademakers, Saskia E, Roesink, Judith M, Nijziel, Marten R, Bilgin, Yavuz M, Aleman, Berthe M P, van Leeuwen, Flora E

Volltext

LONG‐TERM FOLLOW‐UP AND BIOMARKER ANALYSES OF BRENTUXIMAB VEDOTIN AND DHAP IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS: THE HOVON/LLPC TRANSPLANT BRAVE STUDY von Driessen, J., Kersten, M. J., Visser, L., van den Berg, A., Zijlstra, J. M., Tonino, S. H., Zwezerijnen, G. J., Boellaard, R., Lugtenburg, P. J., Hutchings, M., Nijland, M., Liu, R. D., Morschhauser, F., Brice, P., Gastinne, T., de Jong, D., Hagenbeek, A., Plattel, W. J., Diepstra, A.

Volltext

Dichotomy in NF-KB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering von TROMP, J. M, TONINO, S. H, ELIAS, J. A, JASPERS, A, LUIJKS, D. M, KATER, A. P, VAN LIER, Raw, VAN OERS, Mhj, ELDERING, E

Volltext

PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY von Straten, L., Hosnijeh, F., Straten, L., Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, J., Marijt, E.W., Raymakers, R.A., Koene, H.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.

Volltext

Standards for the Treatment of Relapsed Chronic Lymphocytic Leukemia: A Case-Based Study von Kater, Arnon P, Tonino, Sanne H

Volltext

Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering von Tromp, J M, Tonino, S H, Elias, J A, Jaspers, A, Luijks, D M, Kater, A P, van Lier, R A W, van Oers, M H J, Eldering, E

Volltext

Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease von De Bruyne, Bernard, Pijls, Nico H.J, Kalesan, Bindu, Barbato, Emanuele, Tonino, Pim A.L, Piroth, Zsolt, Jagic, Nikola, Mobius-Winckler, Sven, Rioufol, Gilles, Witt, Nils, Kala, Petr, MacCarthy, Philip, Engström, Thomas, Oldroyd, Keith G, Mavromatis, Kreton, Manoharan, Ganesh, Verlee, Peter, Frobert, Ole, Curzen, Nick, Johnson, Jane B, Jüni, Peter, Fearon, William F

Volltext

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention von Tonino, Pim A.L, De Bruyne, Bernard, Pijls, Nico H.J, Siebert, Uwe, Ikeno, Fumiaki, van `t Veer, Marcel, Klauss, Volker, Manoharan, Ganesh, Engstrøm, Thomas, Oldroyd, Keith G, Ver Lee, Peter N, MacCarthy, Philip A, Fearon, William F

Volltext